A master cancer gene hijacks a ‘molecular crowbar’ to make breast cancer cells invasive January 22, 2021
The price of a drug should be based on its therapeutic benefits – not just what the market will bear January 19, 2021
A master cancer gene hijacks a ‘molecular crowbar’ to make breast cancer cells invasive January 22, 2021
The price of a drug should be based on its therapeutic benefits – not just what the market will bear January 19, 2021
Melanoma Use of pembrolizumab provided long-term benefits in patients with metastatic melanoma, 10-year look shows July 21, 2020 A new 10-year analysis led by Igor Puzanov, MD, MSci, FACP, Director of Early Phase…
Cancer Drug News One-two punch drug combination offers hope for pancreatic cancer therapy November 19, 2019 Scientists at Sanford Burnham Prebys Medical Discovery Institute, USA, have identified a combination of two…